Stuart Lai. Based in New York City, Stuart is partially retired focused now on bringing financial technology to the cloud. He was a founding member and the Technology Architect for REDI Technologies. Previously, he managed a 60-person team that originally developed the REDI EMS system at Goldman Sachs.
Having been at the heart of the financial technology revolution, he now sees a similar revolution happening in the biotech field.
"It is heady time for biotechnology in general and FSHD research in particular as we approach the knee of the curve. The very nature of the technology acceleration curve is that the seemingly impossible becomes inevitable if you can keep to the course. I thought it to be impossible before, but my true hope today is that in our lifetime, we will have an effective therapy for our FSHD family. “